Guardant Health (GH) Appoints Myrtle Potter to Its Board

Go back to Guardant Health (GH) Appoints Myrtle Potter to Its Board

Guardant Health Appoints Myrtle Potter to Its Board of Directors

October 20, 2021 4:30 PM UTC

REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has appointed Myrtle Potter to serve on its Board of Directors.

We are very pleased to welcome Myrtle Potter to our Board of Directors as we continue to build and deliver on our mission of conquering cancer with data, said Helmy Eltoukhy, Guardant Health Co-CEO and Chairman of the Board. Myrtle has extensive knowledge and experience bringing world-class therapeutics to market, and her industry expertise will be invaluable as we strive to provide patients across... More